BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27470571)

  • 21. Suppression of vascular endothelial growth factor via inactivation of eukaryotic elongation factor 2 by alkaloids in Coptidis rhizome in hepatocellular carcinoma.
    Tan HY; Wang N; Tsao SW; Zhang Z; Feng Y
    Integr Cancer Ther; 2014 Sep; 13(5):425-34. PubMed ID: 24363282
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ta1722, an anti-angiogenesis inhibitor targeted on VEGFR-2 against human hepatoma.
    Zheng L; He X; Ma W; Dai B; Zhan Y; Zhang Y
    Biomed Pharmacother; 2012 Oct; 66(7):499-505. PubMed ID: 22854322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ultrasound-Stimulated Microbubbles Enhance Radiosensitization of Nasopharyngeal Carcinoma.
    Deng H; Cai Y; Feng Q; Wang X; Tian W; Qiu S; Wang Y; Li Z; Wu J
    Cell Physiol Biochem; 2018; 48(4):1530-1542. PubMed ID: 30071515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antitumor and anti-angiogenic effects of manumycin on human hepatocellular carcinoma HepG2 xenografts in nude mice].
    Zhou JM; Zhu XF; Liu ZC; Fu LW; Yang XP; Liang YJ; Pan QC
    Ai Zheng; 2005 Aug; 24(8):935-9. PubMed ID: 16086869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti‑angiogenic therapy for normalization of tumor vasculature: A potential effect of Buyang Huanwu decoction on nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potential.
    Min L; Ling W; Hua R; Qi H; Chen S; Wang H; Tang L; Shangguan W
    Mol Med Rep; 2016 Mar; 13(3):2518-26. PubMed ID: 26846752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
    BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antitumor and Antiangiogenic Activities of Lenvatinib in Mouse Xenograft Models of Vascular Endothelial Growth Factor-Induced Hypervascular Human Hepatocellular Carcinoma.
    Adachi Y; Matsuki M; Watanabe H; Takase K; Kodama K; Matsui J; Funahashi Y; Nomoto K
    Cancer Invest; 2019; 37(4-5):185-198. PubMed ID: 31006280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sprengerinin C exerts anti-tumorigenic effects in hepatocellular carcinoma via inhibition of proliferation and angiogenesis and induction of apoptosis.
    Zeng KW; Li N; Dong X; Ma ZZ; Jiang Y; Jin HW; Tu PF
    Eur J Pharmacol; 2013 Aug; 714(1-3):261-73. PubMed ID: 23684542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-dose metronomic chemotherapy with cisplatin: can it suppress angiogenesis in H22 hepatocarcinoma cells?
    Shen FZ; Wang J; Liang J; Mu K; Hou JY; Wang YT
    Int J Exp Pathol; 2010 Feb; 91(1):10-6. PubMed ID: 20096070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Huaier polysaccharide restrains hepatocellular carcinoma growth and metastasis by suppression angiogenesis.
    Li C; Wu X; Zhang H; Yang G; Hao M; Sheng S; Sun Y; Long J; Hu C; Sun X; Li L; Zheng J
    Int J Biol Macromol; 2015 Apr; 75():115-20. PubMed ID: 25597429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blockade of an angiotensin type I receptor enhances effects of radiation on tumor growth and tumor-associated angiogenesis by reducing vascular endothelial growth factor expression.
    Ohnuma Y; Toda M; Fujita M; Hosono K; Suzuki T; Ogawa Y; Amano H; Kitasato H; Hayakawa K; Majima M
    Biomed Pharmacother; 2009 Feb; 63(2):136-45. PubMed ID: 18691848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of VEGF165/VEGFR2-dependent signaling by LECT2 suppresses hepatocellular carcinoma angiogenesis.
    Chen CK; Yu WH; Cheng TY; Chen MW; Su CY; Yang YC; Kuo TC; Lin MT; Huang YC; Hsiao M; Hua KT; Hung MC; Kuo ML
    Sci Rep; 2016 Aug; 6():31398. PubMed ID: 27507763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Candesartan stimulates reparative angiogenesis in ischemic retinopathy model: role of hemeoxygenase-1 (HO-1).
    Shanab AY; Elshaer SL; El-Azab MF; Soliman S; Sabbineni H; Matragoon S; Fagan SC; El-Remessy AB
    Angiogenesis; 2015 Apr; 18(2):137-50. PubMed ID: 25420481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibitory effects of cyclooxygenase-2 inhibitor celecoxib on growth and angiogenesis of human liver cancer HepG2 cell xenografts in small nude mice].
    Zuo CH; Li ZR; Zhou X; Ouyang YZ; Zhou ZY; Zeng L
    Ai Zheng; 2006 Apr; 25(4):414-20. PubMed ID: 16613672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer.
    Tanaka N; Miyajima A; Kosaka T; Shirotake S; Hasegawa M; Kikuchi E; Oya M
    Mol Cancer Ther; 2010 Nov; 9(11):2982-92. PubMed ID: 20978160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EphA1 receptor silencing by small interfering RNA has antiangiogenic and antitumor efficacy in hepatocellular carcinoma.
    Chen G; Wang Y; Zhou M; Shi H; Yu Z; Zhu Y; Yu F
    Oncol Rep; 2010 Feb; 23(2):563-70. PubMed ID: 20043122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Suppression of tumor proliferation and angiogenesis of hepatocellular carcinoma by HS-104, a novel phosphoinositide 3-kinase inhibitor.
    Jung KH; Zheng HM; Jeong Y; Choi MJ; Lee H; Hong SW; Lee HS; Son MK; Lee S; Hong S; Hong SS
    Cancer Lett; 2013 Jan; 328(1):176-87. PubMed ID: 22902995
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reexpression of ARHI inhibits tumor growth and angiogenesis and impairs the mTOR/VEGF pathway in hepatocellular carcinoma.
    Zhao X; Li J; Zhuo J; Cai L
    Biochem Biophys Res Commun; 2010 Dec; 403(3-4):417-21. PubMed ID: 21093415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.